🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Matthew J. Atherton

University of Pennsylvania

ORCID: 0000-0002-9830-3151

Also affiliated with Philadelphia University

Biochemistry, Genetics and Molecular BiologyMedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “Veterinary Cooperative Oncology Group—Common Terminology Criteria for Adverse Events (VCOG‐CTCAE v2) following investigational therapy in dogs and cats”.

Veterinary Cooperative Oncology Group—Common Terminology Criteria for Adverse Events (VCOG‐CTCAE v2) following investigational therapy in dogs and cats

Veterinary and Comparative Oncology(2021)10.1111/vco.12677
N/A
0DataRank · unranked
325 citations

Matthew J. Atherton, R. Timothy Bentley, C. Elizabeth Boudreau, Jenna H. Burton, Kaitlin M. Curran +15 more

Genetic re-direction of canine primary T cells for clinical trial use in pet dogs with spontaneous cancer

STAR Protocols(2021)10.1016/j.xpro.2021.100905
N/A
0DataRank · unranked
24 citations

Matthew J. Atherton, Brian Kasper, Kumudhini Preethi Haran, Nicola J. Mason, Antonia Rotolo

Tumor factors stimulate lysosomal degradation of tumor antigens and undermine their cross-presentation in lung cancer

Nature Communications(2022)10.1038/s41467-022-34428-w
N/A
0DataRank · unranked
33 citations

Jinyun Chen, Pengfei Yu, Matthew J. Atherton, Jun Gui, Vivek S. Tomar +10 more

Case Report: Clinical and Serological Hallmarks of Cytokine Release Syndrome in a Canine B Cell Lymphoma Patient Treated With Autologous CAR-T Cells

Frontiers in Veterinary Science(2022)10.3389/fvets.2022.824982
N/A
0DataRank · unranked
15 citations

Antonia Rotolo, Kumudhini Preethi Haran, Nicola J. Mason, Matthew J. Atherton

Unedited allogeneic iNKT cells show extended persistence in MHC-mismatched canine recipients

Cell Reports Medicine(2023)10.1016/j.xcrm.2023.101241
N/A
0DataRank · unranked
22 citations

Eoin C. Whelan, Matthew J. Atherton, Irina Kulikovskaya, Danuta Jarocha, Joseph A. Fraietta +8 more

Applications and Opportunities for Immune Cell CAR Engineering in Comparative Oncology

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-23-3690
N/A
0DataRank · unranked
5 citations

Matthew J. Atherton, Antonia Rotolo

Quantification of CD3, FoxP3, and granzyme B immunostaining in canine renal cell carcinoma

Veterinary Immunology and Immunopathology(2024)10.1016/j.vetimm.2024.110741
N/A
0DataRank · unranked
1 citations

Hayley Amerman, Charles-Antoine Assenmacher, Amy C. Durham, James A. Perry, Allison Gedney +4 more

Immune profiling of canine B cell lymphoma reveals cross-species conservation of prognostic markers

Scientific Reports(2025)10.1038/s41598-025-13389-2
N/A
0DataRank · unranked
1 citations

Jennifer Lenz, Brandon Peng, Audrey Ghanian, Lang Jiang, Matthew J. Atherton +1 more

Younger Age Is Associated with Favorable Outcomes in Adult Dogs with Hemangiosarcoma Receiving Adjuvant Doxorubicin Chemotherapy: Results from the PRO-DOX Study

Research Square(2025)10.21203/rs.3.rs-6573099/v1
N/A
0DataRank · unranked
0 citations

Brian D. Husbands, Aaron L. Sarver, Jeremy M. Chacón, Todd E. DeFor, Aaron Rendahl +18 more

Systemic STING agonist therapy drives expression of interferon stimulated genes and downstream production of cytokines in dogs with solid tumors

Journal for ImmunoTherapy of Cancer(2025)10.1136/jitc-2025-013715
N/A
0DataRank · unranked
0 citations

June DiBona, Matthew J. Atherton, Sumita Roy–Ghanta, Hank Schmidt, Timothy Hart +2 more